F16.98 Hallucinogen use, unspecified with other specified hallucinogen-induced disorder

Name of the Condition

• Hallucinogen Use, Unspecified with Other Specified Hallucinogen-Induced Disorder
• Medical Term: ICD-10-CM F16.98

Summary

Hallucinogen use, unspecified with other specified hallucinogen-induced disorder refers to the use of hallucinogenic substances associated with a clinically recognized disorder induced by hallucinogens, where the specific pattern of use is not detailed. This code is applied when documentation confirms hallucinogen exposure and an associated disorder (e.g., hallucinogen persisting perception disorder, anxiety disorder) but does not specify abuse, dependence, or intoxication. It is used for cases where a hallucinogen-induced disorder is present without further classification of the use pattern.

Causes

Hallucinogen use, unspecified with other specified hallucinogen-induced disorder typically involves substances that alter perception, mood, or cognitive function, such as LSD, psilocybin, or mescaline. The induced disorder arises from the physiological or psychological effects of these substances, though the documentation does not specify a problematic pattern beyond the associated condition. Psychological factors like curiosity or social influences may contribute to initiation, but the focus is on the resulting disorder.

Risk Factors

• Recreational or experimental use of hallucinogens
• Pre-existing mental health conditions
• Genetic predisposition to substance use disorders
• Social or peer pressure to use drugs
• Access to hallucinogenic substances

Symptoms

• Persistent perceptual disturbances (e.g., visual snow, geometric hallucinations)
• Anxiety or panic attacks
• Mood changes, including depression or irritability
• Impaired cognitive function (e.g., memory, attention)
• Sleep disturbances

Diagnosis

Diagnosis requires clinical evaluation to confirm hallucinogen use and the presence of a specified hallucinogen-induced disorder. Documentation must link the substance use to the disorder, though the pattern of use (e.g., abuse, dependence) is not detailed. Laboratory tests or imaging may support the diagnosis, but clinical correlation is essential. The code is applied when the induced disorder is identified but the use pattern remains unspecified.

Treatment Options

Treatment focuses on managing the hallucinogen-induced disorder and addressing underlying substance use. Interventions may include psychotherapy (e.g., cognitive-behavioral therapy) to address anxiety or perceptual disturbances, pharmacotherapy for symptom relief (e.g., anxiolytics), and education on substance risks. Supportive care and referral to addiction specialists may be necessary if problematic use is suspected.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the induced disorder and response to treatment. Some symptoms (e.g., perceptual disturbances) may persist long-term, while others improve with intervention. Regular follow-up is recommended to monitor symptoms, adjust treatment, and assess for recurrence or progression of substance use.

Complications

• Chronic perceptual disturbances
• Worsening mental health conditions (e.g., anxiety, depression)
• Impaired daily functioning (e.g., work, relationships)
• Increased risk of accidental injury due to altered perception

Lifestyle & Prevention

• Avoiding hallucinogenic substances to prevent recurrence of symptoms
• Practicing stress-reduction techniques (e.g., mindfulness, exercise)
• Seeking support from mental health professionals or support groups
• Educating oneself on the risks of hallucinogen use

When to Seek Professional Help

Seek immediate medical attention if symptoms worsen, interfere with daily life, or include severe anxiety, panic, or suicidal thoughts. Consult a healthcare provider for persistent perceptual disturbances or if substance use becomes problematic.

Tips for Medical Coders

Use F16.98 when clinical documentation confirms hallucinogen use and an associated specified hallucinogen-induced disorder (e.g., persisting perception disorder) but does not specify the pattern of use (e.g., abuse, dependence). Ensure the disorder is clearly linked to hallucinogen exposure in the record. Do not use this code if the induced disorder is unspecified or if the use pattern is detailed (e.g., intoxication, withdrawal).